期刊文献+

紧密连接相关蛋白在肺癌脑转移瘤中的表达及临床意义 被引量:2

Expression and clinical significance of tight junction proteins in brain metastases from lung cancer
下载PDF
导出
摘要 目的探讨血脑屏障(BBB)紧密连接相关蛋白claudin 5、occludin及ZO-1在肺癌脑转移瘤中的表达及其临床意义。方法采用免疫组织化学法检测肺癌脑转移瘤组织及正常脑组织中claudin 5、occludin、ZO-1蛋白的表达,并分析紧密连接蛋白表达水平与肺癌脑转移瘤患者临床特征及生存期的关系。结果肺癌脑转移瘤组织中claudin 5、occludin、ZO-1的高表达率均低于正常脑组织(P<0.05);claudin 5、occludin、ZO-1蛋白的表达与肺癌脑转移瘤患者的年龄、病灶个数有关(P<0.05);三种蛋白高表达组患者的中位总生存时间均长于其低表达组患者(P<0.05)。结论紧密连接相关蛋白claudin 5、occludin、ZO-1表达下调可能在脑转移瘤的发生中起到一定的作用。 Objective To investigate the expression of tight junction associated proteins claudin 5, occludin and ZO-1 in brain metastases from lung cancer and their clinical significance. Method Immunohistochemistry assay was used to detect the expression of claudin 5, occludin and ZO-1 protein in brain metastases from lung cancer and normal brain tissues. The correlation between claudin 5, occludin and ZO-1 expression and the clinical characteristics, as well as survival time was analyzed. Result Expression level of tight junction proteins were lower in brain metastasis tissues compared with normal brain tissues(P〈0.05); furthermore, the expression of claudin 5, occludin and ZO-1 showed obvious correlation with patients’ age and the number of lesion(P〈0.05); and high expression level of the three proteins was related to longer median survival time(P〈0.05). Conclusion Decreased expression of claudin 5, occludin and ZO-1 may play an important role in the occurrence of brain metastasis from lung cancer.
作者 鄢少聪 应学明 YAN Shaocong;YING Xuelning(Department of Oncology, the First People's Hospital of Jingdezhen, Jingdezhen 333000, Jiangxi, Chin)
出处 《癌症进展》 2018年第4期475-479,共5页 Oncology Progress
关键词 肺癌脑转移瘤 免疫组织化学 CLAUDIN 5 OCCLUDIN ZO-1 brain metastases from lung cancer immunohistochemistry claudin 5 occludin zonula occludens-1
  • 相关文献

参考文献4

二级参考文献51

  • 1刘晓宏,饶明俐,加藤宏之.实验性脑缺血后CuZn-SOD和Mn-SOD的免疫组化研究[J].中风与神经疾病杂志,1994,11(4):195-198. 被引量:20
  • 2潘晓玉,王波.紧密连接蛋白claudins与肿瘤的研究进展[J].国际病理科学与临床杂志,2006,26(2):113-115. 被引量:12
  • 3Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia[J]. Pharmacol Bichem Behav, 2007, 87:179-197.
  • 4Pardridge, W M. Blood-brain barrier drug targeting: the future of brain drug development[J]. Mol Interv, 2003, 3:90-105.
  • 5Liu Y, Lu JB, Ye ZR. Permeability of injured blood brain barrier for exogenous bFGF protection mechanism of bFGF in rat brain Ischemia[J]. Neuropathology, 2006, 26: 257-266.
  • 6Ueno M. Molecular anatomy of the brain endothelial barrier: an overview of the distributional features[J], Curr Med Chem, 2007, 14(11): 1199-206.
  • 7Yamamoto M, Ramirez SH, Sato S, et al. Phosphorylation of claudin- 5 and occludin by rho kinase in brain endothelial cells[J]. Am J Pathol, 2008, 172(2): 521-533.
  • 8Fisher S, Wiesnet M, Marti HH, et al. Simultaneous activation of several second messengers in hypoxia-induced hyperpermeability of brain derived endothelial cells[J]. J Cell Physiol, 2004,198: 359-369.
  • 9WachtelM, Frei K, Ehler E, et al. Extracellular signal regulated protein kinase activation during reoxygenation is required to restore ischaemia induced endothelial barrier failure[J]. Biochem J, 2002, 367: 873-879.
  • 10Furuse M,Hirase T,Itoh M,et al.Occludin:a novel integralmembrane protein localizing at tight junctions[J].J Cell Biol,1993,123(6):1777-88.

共引文献41

同被引文献10

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部